D-803-2013 Class III Terminated
FDA drug recall D-803-2013 was initiated by Teva Pharmaceuticals USA, Inc. on Jun 18, 2013 and is designated Class III. Reason for recall: Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050. The recall status is terminated (terminated Dec 24, 2013). Affected quantity: 109,080 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 24, 2013
- Initiation Date
- Jun 18, 2013
- Termination Date
- Dec 24, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 109,080 Bottles
Product description
Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960.
Reason for recall
Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.
Distribution pattern
Nationwide
Code information
Lot #s: a) 35426557A, 35426558A, Exp 08/14; b) 35426554A, 35426555A, 35426556A, Exp 08/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-803-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026